Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.65 +0.36 (+1.48%)
Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 132,769,719
Open 24.28
Bid (Size) 24.65 (32)
Ask (Size) 24.73 (33)
Prev. Close 24.29
Today's Range 24.16 - 24.73
52wk Range 20.91 - 28.64
Shares Outstanding 5,606,688,356
Dividend Yield 6.98%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pfizer Sues Novo Nordisk And Metsera To Block The Proposed $6.5 Billion Deal
Pfizer sued Metsera and Novo Nordisk on Friday to prevent Novo's proposed $6.5 billion takeover of the smaller company. 
Via Investor's Business Daily
Topics Law Enforcement Lawsuit
US Government Shutdown Threatens Deeper Economic Drag, BMO Warns
The United States is grappling with the severe economic fallout of a prolonged government shutdown, now stretching through the entire month of October 2025. With federal operations curtailed and... 
Via MarketMinute
Topics Economy

Performance

YTD
-7.4%
-7.4%
1 Month
-9.4%
-9.4%
3 Month
+4.9%
+4.9%
6 Month
+1.9%
+1.9%
1 Year
-12.9%
-12.9%

More News

Read More
Pfizer Files Lawsuit Against Metsera and its Directors and Novo Nordisk for Breach of Merger Agreement
From Pfizer Inc.
Via Business Wire
Retail Investors Now Expect Viking Therapeutics To Bag A Deal After Novo Nordisk, Pfizer Engage In A Bidding War For Rival Metsera
Via Stocktwits
Novo Nordisk Submits Revised Bid For Metsera, Enters A Bidding War With Pfizer
Via Stocktwits
Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout
Via MarketMinute
Topics Intellectual Property
Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition
From Pfizer Inc.
Via Business Wire
Why Bio-Techne (TECH) Stock Is Up Today
Via StockStory
Topics Artificial Intelligence Supply Chain World Trade
Which S&P500 stocks are the most active on Friday?
Via Chartmill
The AI Imperative: Why Rapid Upskilling is Non-Negotiable for Pharma’s Future
Via TokenRing AI
Topics Artificial Intelligence Economy
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
Via TokenRing AI
Topics Artificial Intelligence Supply Chain
AI Revolutionizes Pharma Supply Chains: A New Era of Localized Resilience and Efficiency
Via TokenRing AI
Topics Artificial Intelligence Economy Fraud
AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
Why iRhythm (IRTC) Stock Is Trading Up Today
Via StockStory
Topics Artificial Intelligence World Trade
AbbVie Beats Third-Quarter Forecasts As Immunology Kingpin Grows 47%
Via Investor's Business Daily
Viking Therapeutics Stock Powers Toward Best Month Of The Year — Wall Street, Retail Bulls Fired Up On Obesity Drug Promise
Via Stocktwits
1 Safe-and-Steady Stock with Competitive Advantages and 2 We Turn Down
Via StockStory
Edwards Lifesciences Pops As Third-Quarter Beat Lifts 2025 Guidance
Via Investor's Business Daily
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain
Via Benzinga
Topics ETFs
Thursday's session: most active stock in the S&P500 index
Via Chartmill
Check out the stocks that are attracting the most attention and driving market activity.
Via Chartmill
Novo Nordisk Kicks Off Bloody Battle With Pfizer, Bidding $6.5 Billion On Metsera
Via Investor's Business Daily
Topics Economy Government
Pfizer Blasts Novo Nordisk's $9 Billion Counteroffer For Metsera As 'Reckless'
Via Benzinga
Alnylam Stock Has Already Doubled In 2025. Why It Could Rocket Again On Earnings.
Via Investor's Business Daily

Frequently Asked Questions

Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 24.65
When was Pfizer last traded?
The last trade of Pfizer was at 10/31/25 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 138.20B
How many shares of Pfizer are outstanding?
Pfizer has 138B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.